- Home
- ALLO vs DMII Comparison
ALLO vs DMII Comparison
Compare ALLO & DMII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.63
Company Overview
Basic Information| Metric | ALLO | DMII |
|---|---|---|
| Founded | 2017 | 2024 |
| Country | United States | United States |
| Employees | 152 | 2 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.1M | 647.2M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ALLO | DMII |
|---|---|---|
| Price | $1.63 | $10.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $8.35 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 60.8K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $9.87 |
| 52 Week High | $4.46 | $10.33 |
Technical Indicators
Market Signals| Indicator | ALLO | DMII |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 54.31 |
| Support Level | $1.59 | $10.12 |
| Resistance Level | $2.22 | $10.21 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 14.55 | 5.56 |
Price Performance
Historical Comparison ALLO
DMII
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About DMII Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp is a blank check Company.